Nootropics Market Analysis | 2024-2030

Nootropics Market Analysis | 2024-2030

Nootropics Market Analysis | 2024-2030
Report code - SRHL255 Delivery - 2 Weeks
Nootropics Market Size, Share, Trends, Dynamics, Forecast, & Growth Analysis: 202 See more...

Market Insights

The nootropics market was estimated at USD 3.7 billion in 2023 and is likely to grow at a CAGR of 14.67% during 2024-2030 to reach USD 9.66 billion in 2030.

Nootropics-Market-Insights

To learn more about this report, Request a Sample Here.

Market Dynamics

Introduction

Nootropics are drugs or supplements that are consumed by sportsmen and adults to enhance memory and other cognitive abilities. These are available in both OTC form and prescription drug type, wherein prescription nootropics are drugs that are used to treat diseases such as ‘attention deficit hyperactivity disorder’ (ADHD), Alzheimer’s disease, and narcolepsy. Whereas non-prescription drugs or OTC do not treat diseases but are consumed for improving brain performance and concentration capabilities.

COVID-19 IMPACT

The COVID-19 pandemic has positively influenced the nootropics industry. Concern over COVID-19, unemployment, and poor economic growth has resulted in a rise in the consumer’s stress levels which puts a strain on overall brain health. Thus, there has been a significant demand for nootropics that boost the mood and help to manage stress during this hard time, thus augmenting the market growth.

Market Drivers

Increasing demand for smart drugs and brain boosters is likely to augment the demand for nootropics.

  • A large number of professionals and students consume these smart drugs to enhance memory and focus.
  • Continuous product development using both natural and synthetic raw materials is further expected to propel market growth.
  • Furthermore, the surge in the vegan population in developed countries of Europe and North America is further expected to boost the need for plant-based nootropic products.
  • In addition, the surging demand for multi-utility drugs that work as energy boosters, antidepressants, and anxiety resistance further offer immense opportunities to product manufacturers.

Nootropics-Market-Dynamics

Want to have a closer look at this market report? Register Here

Key Players

Key players operating in the nootropics market are:

  • Accelerated Intelligence Inc. (UK),
  • AlternaScript (The U.S),
  • HVMN (The U.S),
  • Onnit Labs, Inc. (The U.S),
  • Peak Nootropics (The U.S),
  • Teva Pharmaceutical Industries (Israel),
  • Purelife Bioscience Co., Ltd. (China),
  • United Pharmacies (Moldova), SupNootropic Bio Co.,ltd (The U.S), and
  • Powder City (The U.S).

Note: The above list does not necessarily include all the top players in the market.

Are you the leading player in this market? We would love to include your name. Write to us at sales@stratviewresearch.com

Segment Analysis

Segmentations

List of Sub-Segments

Segments with High Growth Opportunity

Distribution Channel Type Analysis

Offline and Online.

The online segment held a substantial market share in 2023 and is projected to register a robust CAGR of almost 14% during the review period.

Regional Analysis

North America, Europe, Asia-Pacific, and Rest of the World

North America dominated the nootropics market in 2023 with an astounding share of more than 40% and is projected to grow at a healthy CAGR during the review period.

By Distribution Channel Type

Based on distribution channels, the nootropics market has been bifurcated into offline and online.

  • Among these, the online segment held a substantial market share in 2023 and is projected to register a robust CAGR of almost 14% during the review period.
  • This is mainly attributed to the growing preference for nootropics by students.
  • Easy payment platforms that fit into the regulatory standards of various countries have made payment operations easier.
  • Thus, key industry participants focus on online distribution channels to widen their customer base.

Regional Insights

By region, North America dominated the nootropics market in 2023 with an astounding share of more than 40% and is projected to grow at a healthy CAGR during the review period.

  • This can be attributed to the presence of major healthcare companies, increasing consumer awareness about brain health, and changing lifestyles are expected to boost regional growth.
  • Around 50% of the adult population in the US consumes vitamin supplements, this is a key contribution to the regional nootropic industry.

Nootropics-Market-Regional-Insights

Know the high-growth countries in this report. Register Here

Research Methodology

  • This strategic assessment report from Stratview Research provides a comprehensive analysis that reflects nootropics market realities and future market possibilities for the forecast period.
  • The report segments and analyzes the market in the most detailed manner in order to provide a panoramic view of the market.
  • The vital data/information provided in the report can play a crucial role for market participants as well as investors in the identification of the low-hanging fruits available in the market as well as to formulate growth strategies to expedite their growth process.
  • This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.
  • More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data.
  • We conducted more than 15 detailed primary interviews with market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.

Report Features

This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into market dynamics and will enable strategic decision-making for existing market players as well as those willing to enter the market. The following are the key features of the report:

  • Market structure: Overview, industry life cycle analysis, supply chain analysis.
  • Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis.
  • Market trend and forecast analysis.
  • Market segment trend and forecast.
  • Competitive landscape and dynamics: Market share, Service portfolio, New Product Launches, etc.
  • COVID-19 impact and its recovery curve
  • Attractive market segments and associated growth opportunities.
  • Emerging trends.
  • Strategic growth opportunities for the existing and new players.
  • Key success factors.

Market Segmentation

This report studies the market covering a period of 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision-making and growth strategy formulation based on the opportunities present in the market.

The nootropics market is segmented into the following categories:

By Drug Type

  • Prescription Nootropics
  • OTC Nootropics

By Application Type

  • Memory Enhancement
  • Mood & Depression
  • Attention & Focus
  • Longevity & Anti-aging
  • Sleep & Recovery
  • Anxiety

By Distribution Channel Type

  • Online
  • Offline

By Region

  • North America (Country Analysis: the USA, Canada, and Mexico)
  • Europe (Country Analysis: Germany, France, the UK, Russia, Spain, and the Rest of Europe)
  • Asia-Pacific (Country Analysis: China, Japan, India, South Korea, and the Rest of Asia-Pacific)
  • Rest of the World (Sub-Region Analysis: Latin America, the Middle East, and Others)

Nootropics-Market-Segmentation

Want to know the most attractive market segments? Register Here

Report Customization Options

With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

Company Profiling

  • Detailed profiling of additional market players (up to 3 players)
  • SWOT analysis of key players (up to 3 players)

Market Segmentation

  • Current market segmentation of any one of the drug types by distribution channel type.

Competitive Benchmarking

  • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.

Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.

Frequently Asked Questions (FAQs)

Nootropics are drugs or supplements that are consumed by sportsmen and adults to enhance memory and other cognitive abilities. These are available in both OTC form and prescription drug type, wherein prescription nootropics are drugs that are used to treat diseases such as ‘attention deficit hyperactivity disorder’ (ADHD), Alzheimer’s disease, and narcolepsy. Whereas non-prescription drugs or OTC do not treat diseases but are consumed for improving brain performance and concentration capabilities.

The nootropics market was estimated at USD 3.7 billion in 2023.

The nootropics market is likely to reach USD 9.66 billion in 2030.

The nootropics market is likely to grow at a CAGR of 14.67% during 2024-2030.

Accelerated Intelligence Inc. (UK), AlternaScript (The U.S), HVMN (The U.S), Onnit Labs, Inc. (The U.S), Peak Nootropics (The U.S), Teva Pharmaceutical Industries (Israel), Purelife Bioscience Co., Ltd. (China), United Pharmacies (Moldova), SupNootropic bio co.,ltd (The U.S) and Powder City (The U.S) are among the top players in the market.

North America dominated the nootropics market in 2023 with an astounding share of more than 40% and is projected to grow at a healthy CAGR during the review period.

Increasing demand for smart drugs and brain boosters, continuous product development using both natural and synthetic raw materials, and the surge in the vegan population in developed countries of Europe and North America are the factors driving the growth of the market.

The online segment held a substantial market share in 2023 and is projected to register a robust CAGR of almost 14% during the review period.